Get the ChemPriceHub app — track prices on the go. Membership syncs across app & web. View plans
 
Home > News > [Fine Chemicals] Latest research progress on ergothioneine in 2025-2026: mechani...

[Fine Chemicals] Latest research progress on ergothioneine in 2025-2026: mechanism analysis, green production, and new application breakthroughs

Wei Zhang
Published on 2026-11-17

[Fine Chemicals] Latest research progress on ergothioneine in 2025-2026: mechanism analysis, green production, and new application breakthroughs

A breakthrough published in Cell Metabolism in 2025 fully clarified, for the first time, the core pathway by which ergothioneine regulates healthy aging in the body. Using C. elegans and aged rats as models, the study confirmed that ergothioneine can bidirectionally regulate metabolism and the aging process through the CSE-H₂S-protein persulfidation signaling axis. The research shows that ergothioneine acts as a specific substrate for cystathionine γ-lyase (CSE), activating the body's hydrogen sulfide production pathway and regulating persulfidation modifications of more than 300 target proteins. Among these, cytosolic glycerol-3-phosphate dehydrogenase (cGPDH) is the core effector target, effectively boosting NAD⁺ levels in the body and improving oxidative stress damage, metabolic disorders, and muscle decline in aged individuals. Gene knockout experiments confirmed that without CSE or cGPDH, ergothioneine's anti-aging effects completely disappear, establishing the uniqueness of this pathway. Animal experiments confirmed that exogenous ergothioneine supplementation extends lifespan in model organisms, improves vascular microcirculation, and lowers aging marker levels, providing a new theoretical basis for aging intervention. The latest 2026 proteomics research further refined its mechanism, finding that the MPST enzyme is the key core protein for ergothioneine's targeted mitochondrial protection. By binding to MPST, ergothioneine repairs damaged mitochondria, boosts energy metabolism efficiency, and clears reactive oxygen species, blocking oxidative aging at the organelle level. Meanwhile, multiple synergistic experiments confirmed that combining ergothioneine with glutathione and ferulic acid forms a potent antioxidant system, providing data support for optimizing functional formulations.

II. Biomanufacturing technology: domestic high-yield systems break through industry bottlenecks. The industrialization of ergothioneine has long been limited by technical shortcomings: traditional fungal extraction methods have low yield, poor purity, and high cost; early microbial fermentation required adding expensive exogenous amino acids, making large-scale production extremely difficult. In October 2025, a team from the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, completed a technological innovation, constructing an ultra-high-yield, low-cost E. coli synthesis system that completely broke foreign technological monopolies. Using E. coli as the chassis cell, the study achieved full biosynthesis of ergothioneine through multi-module reconstruction of metabolic pathways, modification of key rate-limiting enzymes, and redistribution of intracellular metabolic flux, without adding expensive precursor amino acids. The optimized strain's fermentation yield increased substantially, far exceeding existing reported levels at home and abroad, while simplifying purification processes and improving product purity, greatly reducing production costs and solving the industry's core pain points. This green manufacturing technology abandons traditional high-pollution, high-cost processes and is suitable for industrial large-scale production, laying the industrial foundation for widespread application of ergothioneine.

III. New progress in application research: clinical and functional breakthroughs in multiple fields

Comments

0
  • Yuki Tanaka 2026-11-17 13:59
    What's more troublesome is that the process is complex, yields are low, and it may use toxic and harmful reagents like formaldehyde and methyl iodide, so safety has always been an issue. 2. Natural biological extraction: direct extraction from edible mushrooms such as porcini, shiitake, and enoki. But the ergothioneine content in these raw materials is generally only 0.1–3 mg/g (dry weight), extremely low. To extract enough of the compound requires massive amounts of raw material, with high extraction costs, complex purification processes, and limitations from raw material sources and growth cycles—making large-scale production fundamentally impossible. 3. Biosynthesis (microbial fermentation): using synthetic biology to construct efficient engineered strains like E. coli and yeast as "cell factories," synthesizing ergothioneine through fermentation. The advantages of this route are obvious: high optical specificity of the product, good bioavailability, a mild and green production process with no solvent pollution, suitable for industrial large-scale production, and controllable costs. With its comprehensive advantages of high purity, high activity, and green sustainability, this has become the mainstream technical direction for ergothioneine production today. But even within biosynthesis, different companies' foundations and capabilities determine the ceiling of the final product. Zhongke Xinyang is a pioneer on this technical path. As one of the world's earliest companies to adopt fully synthetic microbial cell factory production of ergothioneine and achieve large-scale manufacturing, it holds a leading share of the domestic raw material market. Its flagship ingredient SIYOMICRO-ERGO® ergothioneine is different from other companies at the source: the strain comes from ultra-stable microorganisms collected from the extreme environment of the Quzhuomu hot spring in Tibet. Through AI enzyme screening and genetic engineering, the R&D team selected the best genes from tens of thousands of synthases to construct an engineered strain that efficiently synthesizes ergothioneine. The modified engineered bacteria are put into hundred-ton fermentation tanks, using fully synthetic microbial cell factory technology, with large-scale fermentation culture under precisely controlled temperature, pH, dissolved oxygen, and other conditions.
No comments yet.